In a recent National Law Journal article, HSE Partner Alexander R. McClean, chair of the firm’s Securities and Capital Markets Practice Group, discussed the SEC’s approval of a new Nasdaq rule that raises listing standards for smaller public companies. Effective July 23, the rule requires companies to maintain a minimum $5 million market value of listed securities or face delisting after 30 consecutive days below the threshold, without the cure periods typically available for other Nasdaq deficiencies. While Nasdaq and the SEC view the change as a means to strengthen market integrity and protect investors, McClean noted that the rollout has created significant uncertainty for affected issuers. “There’s just a lot of uncertainty right now for implicated companies,” he said. McClean also expressed concern that the rule “paints with a very broad brush,” potentially impacting fundamentally sound companies experiencing temporary challenges. “The way they crafted this rule doesn’t really allow a good company who has a good story that probably should be on Nasdaq to be on Nasdaq,” he said. “They didn’t create enough flexibility here.” He advised smaller issuers to closely monitor their market capitalization and proactively evaluate strategic options to maintain compliance.